IMFINZI-subQ
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Zymeworks BC Inc.
National Cancer Institute (NCI)
7 Hills Pharma, LLC
Nammi Therapeutics Inc
National Cancer Institute (NCI)
OncoC4, Inc.
Regeneron Pharmaceuticals
University Hospital, Angers
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Aptamer Sciences, Inc.
3D Medicines
National Cancer Institute (NCI)
Exelixis
Mayo Clinic
M.D. Anderson Cancer Center
ViroMissile, Inc.
Seagen Inc.
Essen Biotech
OHSU Knight Cancer Institute
DualityBio Inc.
MacroGenics
Hefei TG ImmunoPharma Co., Ltd.
City of Hope Medical Center
Grey Wolf Therapeutics
Jiangsu Simcere Pharmaceutical Co., Ltd.
Wondercel Biotech (ShenZhen)
ImmunityBio, Inc.
Indaptus Therapeutics, Inc
Ocellaris Pharma, Inc.
Mayo Clinic
Incyte Corporation
Degron Therapeutics Co.
Mayo Clinic
GV20 Therapeutics
NeoTX Therapeutics Ltd.
West China Hospital
DualityBio Inc.
Sotio Biotech Inc.
City of Hope Medical Center
Coherus Oncology, Inc.
BioInvent International AB
Pfizer
GONGCHU Biotechnology Co., Ltd
Exelixis
Incyte Corporation
Jonsson Comprehensive Cancer Center